Zealand Pharma A/S (ZEAL) — Cash Flow-to-Debt Ratio
Zealand Pharma A/S (ZEAL) has a Cash Flow-to-Debt Ratio of -0.64x as of December 2025, meaning its operating cash flow of Dkr-1.04 Billion could theoretically repay -1% of its total liabilities (Dkr1.63 Billion) in one year. See ZEAL cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zealand Pharma A/S Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Zealand Pharma A/S across 19 annual periods. Also explore Zealand Pharma A/S net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Zealand Pharma A/S (2007–2025)
Year-by-year debt coverage analysis for Zealand Pharma A/S. For market capitalisation and broader financial context, see ZEAL market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (DKK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 4.00x | Dkr6.53 Billion | Dkr1.63 Billion | ▲ +482.4% |
| 2024 | -1.05x | Dkr-930.82 Million | Dkr888.86 Million | ▲ +4.8% |
| 2023 | -1.10x | Dkr-425.67 Million | Dkr387.15 Million | ▲ +15.5% |
| 2022 | -1.30x | Dkr-942.21 Million | Dkr723.89 Million | ▼ -22.4% |
| 2021 | -1.06x | Dkr-1.21 Billion | Dkr1.14 Billion | ▼ -15.4% |
| 2020 | -0.92x | Dkr-688.72 Million | Dkr747.52 Million | ▲ +19.7% |
| 2019 | -1.15x | Dkr-409.45 Million | Dkr356.84 Million | ▲ +71.7% |
| 2018 | -4.06x | Dkr-460.40 Million | Dkr113.52 Million | ▼ -203.8% |
| 2017 | -1.34x | Dkr-278.75 Million | Dkr208.77 Million | ▼ -1459.3% |
| 2016 | 0.10x | Dkr40.90 Million | Dkr416.43 Million | ▲ +116.7% |
| 2015 | -0.59x | Dkr-225.41 Million | Dkr382.46 Million | ▼ -380.5% |
| 2014 | -0.12x | Dkr-42.18 Million | Dkr343.93 Million | ▲ +97.8% |
| 2013 | -5.51x | Dkr-169.62 Million | Dkr30.77 Million | ▼ -352.4% |
| 2012 | 2.18x | Dkr68.54 Million | Dkr31.39 Million | ▲ +3495.4% |
| 2011 | -0.06x | Dkr-1.81 Million | Dkr28.08 Million | ▲ +95.0% |
| 2010 | -1.29x | Dkr-55.98 Million | Dkr43.44 Million | ▲ +46.0% |
| 2009 | -2.39x | Dkr-61.45 Million | Dkr25.75 Million | ▼ -38.5% |
| 2008 | -1.72x | Dkr-28.62 Million | Dkr16.61 Million | ▲ +37.1% |
| 2007 | -2.74x | Dkr-57.57 Million | Dkr21.00 Million | — |